547 related articles for article (PubMed ID: 21339346)
21. [Highly differentiated liver tumors: recent developments and their diagnostic application].
Schirmacher P; Longerich T
Pathologe; 2009 Dec; 30 Suppl 2():200-6. PubMed ID: 19908045
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomic hybridization. Synchronous occurrence of focal nodular hyperplasia and hepatocellular carcinoma in the same liver is not based on common chromosomal aberrations.
Kellner U; Jacobsen A; Kellner A; Mantke R; Roessner A; Röcken C
Am J Clin Pathol; 2003 Feb; 119(2):265-71. PubMed ID: 12579998
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
[TBL] [Abstract][Full Text] [Related]
25. Imaging of paediatric liver tumours with pathological correlation.
Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S
Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008
[TBL] [Abstract][Full Text] [Related]
26. Hepatic tumors induced by sex steroids.
Mays ET; Christopherson W
Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
[TBL] [Abstract][Full Text] [Related]
27. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular benign tumors-from molecular classification to personalized clinical care.
Nault JC; Bioulac-Sage P; Zucman-Rossi J
Gastroenterology; 2013 May; 144(5):888-902. PubMed ID: 23485860
[TBL] [Abstract][Full Text] [Related]
29. Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification.
Kondo F; Fukusato T; Kudo M
Oncology; 2014; 87 Suppl 1():37-49. PubMed ID: 25427732
[TBL] [Abstract][Full Text] [Related]
30. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
[TBL] [Abstract][Full Text] [Related]
31. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
32. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Yamamoto M; Ariizumi S; Yoshitoshi K; Saito A; Nakano M; Takasaki K
J Surg Oncol; 2006 Dec; 94(7):587-91. PubMed ID: 17066420
[TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
[TBL] [Abstract][Full Text] [Related]
35. Focal nodular hyperplasia mimicking hepatocellular adenoma and carcinoma in two cases.
Zhu M; Li H; Wang C; Yang B; Wang X; Hou F; Yang S; Wang Y; Guo X; Qi X
Drug Discov Ther; 2021 May; 15(2):112-117. PubMed ID: 33952777
[TBL] [Abstract][Full Text] [Related]
36. Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
Tajada M; Nerín J; Ruiz MM; Sánchez-Dehesa M; Fabre E
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):227-30. PubMed ID: 11848652
[TBL] [Abstract][Full Text] [Related]
37. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
38. Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma.
Wilkens L; Bredt M; Flemming P; Mengel M; Becker T; Klempnauer J; Kreipe H
J Hepatobiliary Pancreat Surg; 2002; 9(3):304-11. PubMed ID: 12353141
[TBL] [Abstract][Full Text] [Related]
39. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
[TBL] [Abstract][Full Text] [Related]
40. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
